[HTML][HTML] Continuous positive airway pressure treatment for obstructive sleep apnea, hospitalizations, and related costs in the French National Healthcare Insurance …
AK Sabil, JC Borel, J Texereau, S Bailly… - Respiratory Medicine and …, 2024 - Elsevier
Methods This is a retrospective cohort study based on the representative random sample of
the French healthcare claims database (ie, the Generic Sample of Beneficiaries, GSB, a …
the French healthcare claims database (ie, the Generic Sample of Beneficiaries, GSB, a …
Using Real-World Data to Understand Who Has Cardiovascular Benefits from Continuous Positive Airway Pressure: The Importance of Male Sex, Excessive …
BT Keenan, R Heinzer - … Journal of Respiratory and Critical Care …, 2022 - atsjournals.org
8. Lindstrand A, Galanis I, Darenberg J, Morfeldt E, Naucler P, Blennow M, et al. Unaltered
pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive …
pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive …
Association between healthy behaviors and healthcare resource use with subsequent positive airway pressure therapy adherence in obstructive sleep apnoea.
C Launois, S Bailly, A Sabil, F Goupil, T Pigeanne… - Chest, 2024 - Elsevier
Background The healthy adherer effect (HAE) has gained increasing attention as potential
source of bias in observational studies examining the association of positive airway …
source of bias in observational studies examining the association of positive airway …
Non-contact and non-constraining monitoring of the respiratory rate including sleep disordered breathing using ultra-wideband radar
K Chin, S Okumura, D Endo, K Nagata, T Ito, K Murase… - medRxiv, 2024 - medrxiv.org
Background: The respiratory rate (RR) is a critical vital sign controlled by not only metabolic
factors but behavior while awake. The prevalence of obstructive sleep apnea (OSA) is …
factors but behavior while awake. The prevalence of obstructive sleep apnea (OSA) is …
Association of positive airway pressure termination with mortality and non-fatal cardiovascular events in patients with obstructive sleep apnoea
AK Sabil, C Launois, W Trzepizur, F Goupil… - Thorax, 2024 - thorax.bmj.com
Background and aims The recurrence of obstructive sleep apnoea (OSA) after positive
airway pressure (PAP) therapy termination has physiological consequences that may …
airway pressure (PAP) therapy termination has physiological consequences that may …
[PDF][PDF] From patient-centric personalized approach in sleep medicine–From theory to practice
O Vanderveken - J Dent Sleep Med, 2022 - researchgate.net
A large majority of patients with obstructive sleep apnea (OSA) are currently treated with a
device-therapy, such as continuous positive airway pressure (CPAP), mandibular …
device-therapy, such as continuous positive airway pressure (CPAP), mandibular …
Sleep Hypoxemia Predicts Mortality in Sleep Apnea Patients: A Secondary Analysis of the Sleep Heart Health Study
Background The Sleep Heart Health Study (SHHS) was a prospective cohort study
formulated to explore the risk factors for development of cardiovascular disease in OSA …
formulated to explore the risk factors for development of cardiovascular disease in OSA …
The value of implementing a digital approach in the obstructive sleep apnoea patient pathway: a Spanish example
S Correia, M Gonzalez, M Deger, P Pitts - Open Respiratory Archives, 2024 - Elsevier
Introduction Continuous positive airway pressure (CPAP) is the gold standard therapy for
obstructive sleep apnoea (OSA). However, non-adherence is common and costly. The …
obstructive sleep apnoea (OSA). However, non-adherence is common and costly. The …
CPAP for secondary cardiovascular prevention in obstructive sleep apnoea patients: not only one moon, but many stars
S Baillieul, NM Shah, R Dharmasena, S Schiza… - Breathe, 2022 - Eur Respiratory Soc
While continuous positive airway pressure (CPAP) therapy has a strong evidence base for
the treatment of obstructive sleep apnoea (OSA), its impact on cardiovascular comorbidity …
the treatment of obstructive sleep apnoea (OSA), its impact on cardiovascular comorbidity …
Cardiopathie ischémique et syndrome d'apnées obstructives du sommeil: mécanismes impliqués dans la réponse à l'hypoxie intermittente
M Détrait, E Billoir, É Belaïdi, C Arnaud - Médecine du Sommeil, 2023 - Elsevier
Résumé La présence d'un SAOS chez des patients avec une cardiopathie ischémique est
un facteur de mauvais pronostic. Au cours des apnées, les patients présentent des épisodes …
un facteur de mauvais pronostic. Au cours des apnées, les patients présentent des épisodes …